S. A. Rosenberg, M. T. Lotse, L. M. Mull, S. Leitman, A. E. Chang, J. T. Votto, C. A. Seipp and C. Simpson, “A New Approach to the Therapy of Cancer Based on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukine-2,” Surgery, Vol. 100, No. 2, 1986, pp. 262-272.
 H. Kimura and Y. Yamaguchi, “A Phase Ⅲ Randomized Study of Interleukin-2 Lymphokine-Activated Killer Cell Immunotherapy Combined with Chemotherapy or Radiotherapy after Curative or Non-Curative Resection of Primary Lung Carcinoma,” Cancer, Vol. 80, No. 1, 1997, pp. 42-49.
 T. Takayama, T. Sekine, M. Makuuchi, S. Yamasaki, T. Kosuge, J. Yamamoto, K. Shimada, M. Sakamoto, S. Hirohashi, Y. Ohashi and T. Kakizoe, “Adoptive Immunotherapy to Lower Postsurgical Recurrence Rates of Hepatocellular Carcinoma: A Randomized Trial,” Lancet, Vol. 356, No. 9232, 2000, pp. 802-807. http://dx.doi.org/10.1016/S0140-6736(00)02654-4
 S. Goto, T. Kaneko, Y. Miyamoto, M. Eriguchi, A. Kato, T. Akiyama, K. Fujimoto, H. Tomonaga and K. Egawa, “Combined Immuno-Cell Therapy Using Activated Lymphocytes and Monocytes-Derived Dendritic Cells for Malignant Melanoma,” Anticancer Research, Vol. 25, 2005, pp. 3741-3746.
 T. Kaneko, S. Goto, A. Kato, A. M. Akeyama, K. Tomonaga, Y. Fujimoto, Y. Miyamoto, M. Eriguchi and K. Egawa, “Efficacy of Immuno-Cell Therapy in Patients with Advanced Pancreatic Cancer,” Anticancer Research, Vol. 25, 2005, pp. 3709-3714.
 K. Iwai, K. Soejima, S. Kudoh, Y. Umezato, T. Kanako, K. Yoshimori, H. Tokuda, T. Yamaguchi, A. Mizoo, Y. Setoguchi, T. Kamigaki, Y. Fujimoto and S. Goto, “Extended Survival Observed in Adoptive Activated T Lymphocyte Immunotherapy for Advanced Lung Cancer: Results of a Multicenter Historical Cohort Study,” Cancer ImmunolImmunother, Vol. 61, No. 10, 2012, pp. 1781-1790.
 G. Parmiani and A. Anichini, “T Cell Infiltration and Prognosis in HCC Patients,” Journal of Hepatology, Vol. 45, No. 2, 2006, pp. 178-181. http://dx.doi.org/10.1016/j.jhep.2006.06.005
 G. Shindo, T. Endo, M. Onda, Y. Miyamoto, T. Kaneko and S. Goto, “Immuno-Cell Therapy with Antecedent Surgery Has Superior Actuarial Survival to Immuno-Cell Therapy without Antecedent Surgery for Advanced Cancers,” Cancer Immunology, Immunotherapy, Vol. 60, No. 10, 2011, pp. 1397-1403. http://dx.doi.org/10.1007/s00262-011-1044-0
 K. Egawa, “On the Safety Assurance of All Processing Carried Out on Medical Institutions for Autologous Immune-Cell Therapy,” Human Cell, Vol. 17, No. 1, pp. 1-6. http://dx.doi.org/10.1111/ j.1749-0774.2004.tb00014.x
 S. Goto, A. Noguchi, H. Jinguji and M. Takahara, “The Therapeutic Potential of Immuno-Cell Therapy of Cancer in Combination with Aminobiophosphonates” Anticancer Research, Vol. 26, pp. 3989-3995.
 L. A. Herzenberg, M. H. Julius and T. Masada, “Demonstration That Antigen-Binding Cells Are Precursors of Antibody-Producing Cells after Purification with Fluorescence Activated Cell Sorter,” PNAS, Vol. 69, No. 7, 1972, pp. 1934-1938. http://dx.doi.org/10.1073/pnas.69.7.1934
 A. Agarwal, S. Verma, U. Burra, N. S. Murthy, N. K. Mohanty and S. Saxena, “Flow Cytometric Analysis of Th1 and Th2 Cytokines in PBMCs as a Parameter of Immunological Dysfunction of Superficial Transitional Cell Carcinoma of Bladder,” Cancer Immunology, Immunotherapy, Vol. 55, No. 6, 2006, pp. 734-743. http://dx.doi.org/10.1007/s00262-005-0045-2
 Y. Wada, O. Nakashima, R. Kutami, O. Yamamoto and M. Kojiro, “Clinicopathological Study on Hepatocellular Carcinoma with Lymphocytic Infiltration,” Hepatology, Vol. 27, No. 2, 1998, pp. 404-414. http://dx.doi.org/10.1002/hep.510270214
 D. J. Powell Jr., M. E. Dudley, K. A. Hogan, J. R. Wunderlich and S. A. Rosenberg, “Adopted Transfer of Vaccine-Induced Peripheral Blood Mononuclear Cells to Patients with Metastatic Melanomas Following Lymphodepletion,” The Journal of Immunology, Vol. 177, No. 9, 2006, pp. 6527-6539.
 M. Sakamoto, J. Nakajima, T. Murakawa, T. Fukami, Y. Yoshida, T. Murayama, S. Takamoto, H. Matsushita and K. Kakimi, “Adoptive Immunotherapy for Advanced Non-Small Lung Cancer Using Zoledronate-Expanded γδΤ Cells: A Phase 1 Clinical Study,” The Journal of Immunology, Vol. 34, No. 2, 2011, pp. 202-211.
 E. Ishikawa, K. Tsuboi, K. Saijo, H. Harada, S. Takano, T. Nose and T. Ohno, “Autologous Natural Killer Cell Therapy for Human Recurrent Malignant Glioma,” Anticancer Research, Vol. 24, 2004, pp. 1861-1872.
 A. Kuemmel, K. Single, F. Bittinger, A. Faldum, L. H. Schmidt, M. Sebastia, P. Micke, C. Taube, R. Buhl and R. Wiewrodt, “TA-MUC1 Epitope in Non-Small Cell Lung Cancer,” Lung Cancer, Vol. 63, No. 1, 2009, pp. 98-105. http://dx.doi.org/10.1016/j.lungcan.2008.04.005
 V. Mazzaforro, J. Coppa, M. G. Garrabba, L. Rivoltini, M. Schiavo, E. Regalia, L. Mariani, T. Camerini, A. Marchiano, S. Andreola, R. Camerini, M. Corsi, J. J. Lewis, P. K. Srivastava and G. Parmiani, “Vaccination with Autologous Tumor-Derived Heat-Shock Protein Gp 96 after Liver Resection for Metastatic Colorectal Cancer,” Clinical Cancer Research, Vol. 9, No. 9, 2003, pp. 3235-3245.
 H. Norell, I. Poschke, J. Charo, W. Z. Wei, L. Erskine, M. P. Piechocki, K. L. Knutson, J. Bergh, E. Lidbrink and R. Kiessling, “Vaccination with a Plasmid DNA Encoding HER-2/neu Together with Low Dose of GM-CSF and IL-2 in Patients with Metastatic Breast Carcinoma: A Pilot Clinical Trial,” Journal of Translational Medicine, Vol. 8, No. 6, 2010, pp. 53-64. http://dx.doi.org/10.1186/1479-5876-8-53
 L. A. Emens, “Re-Purposing Cancer Therapeutics for Breast Cancer Immunology,” Cancer Immunology, Immunotherapy, Vol. 61, No. 8, 2012, pp. 1299-1305. http://dx.doi.org/10.1007/ s00262-012-1247-z
 K. Shirabe, T. Motomura, J. Muto, T. Toshima, R. Matono, Y. Mano, K. Takeishi, H. Ijichi, N. Harada, H. Uchiyama, T. Yoshizumi, A. Takatomi and Y. Maehara, “Tumor Infiltrating Lymphocytes and Hepatocellular Carcinoma: Pathology and Clinical Management,” International Journal of Clinical Oncology, Vol. 15, No. 6, 2010, pp. 552-558. http://dx.doi.org/10.1007/s10147-010-0131-0
 B. Fong, R. Jin, X. Wang, M. Safaee, D. N. Lisiero, I. Yang, G. Li, L. M. Liau and R. M. Prins, “Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, Before and after DC Vaccination, Can Predict Survival in GBM Patients,” PLoS ONE, Vol. 7, No. 4, 2012, pp. 1-9.
 P. Salama, C. Stewart, C. Forrest, C. Platell and B. Iacopetta, “FoxP3+ Cell Density in Lymphoid Follicles from Histlogically Normal Mucosa Is a Strong Prognostic Factor in Early Stage Colon Cancer,” Cancer Immunology, Immunotherapy, Vol. 61, No. 8, 2012, pp. 1183-1190. http://dx.doi.org/ 10.1007/s00262-011-1191-3